top
Search terms
Results 1 - 2 of 2 - ordered by :
Escardio

A total of 20 late-breaking trials will be presented across four sessions, covering cardiac devices, innovative techniques to optimise response to cardiac resynchronisation therapy (CRT), new ...

Date : 19/02/2019
Escardio

The results showed that, overall, there was no difference in the non-response to response conversion rate between MPP and BiV (31.8% vs 33.8%, p=0.72). “We had expected MPP to be better than ...

Date : 20/03/2018